Baxter BioPharma Solutions to provide manufacturing services for Novavax’s COVID-19 vaccine candidate 12-Jan-2021 By Rachel Arthur Baxter BioPharma Solutions' sterile manufacturing agreement with Novavax will help increase commercial production of the vaccine in Europe and the UK.